Olga Połukord

Dr. Olga Połukord


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
OPOlga Połukord
Olga Połukord
WJWiktoria JęDrzejak
Wiktoria JęDrzejak
PLPatrycja Loba
Patrycja Loba
MDMaria Depczyńska
Maria Depczyńska
ZRZuzanna Radziszewska
Zuzanna Radziszewska
KCKarolina Chmaj-Wierzchowska
Karolina Chmaj-Wierzchowska
Background: Uterine fibroids (leiomyomas) are the most common benign tumors in women of reproductive age and represent a significant cause of abnormal uterine bleeding, pelvic pain, infertility, and reduced quality of life. Contemporary management has evolved toward individualized, uterus-sparing approaches, incorporating pharmacological and minimally invasive strategies alongside traditional surgical methods. Methods: This narrative review was conducted based on a comprehensive search of PubMed/MEDLINE, Scopus, and Web of Science databases for studies published between January 2010 and December 2025. The search strategy combined Medical Subject Headings (MeSH) and free-text terms related to uterine fibroids and their management. Eligible studies included clinical trials, systematic reviews, and meta-analyses focusing on pharmacological, minimally invasive, and surgical treatments in adult women. The review was prepared in accordance with the Scale for the Assessment of Narrative Review Articles (SANRA) recommendations to improve methodological transparency and quality of reporting. Results: A total of 97 studies were included in the qualitative synthesis. Minimally invasive techniques, including uterine artery embolization (UAE), radiofrequency ablation (RFA), and high-intensity focused ultrasound (HIFU), demonstrate high efficacy in symptom control and improvement of quality of life, with shorter recovery times and lower complication rates compared to conventional surgery. However, their impact on fertility remains variable and requires careful patient selection. Pharmacological therapies, particularly GnRH analogues and antagonists, effectively reduce bleeding and fibroid volume, although their long-term use is limited by side effects. Conclusions: The management of uterine fibroids should be individualized, taking into account symptom severity, fibroid characteristics, patient age, and reproductive plans. Minimally invasive and pharmacological treatments represent effective alternatives to surgery in appropriately selected patients, while surgical approaches remain essential in advanced or refractory cases. Future research should focus on optimizing personalized treatment strategies and evaluating long-term outcomes, particularly regarding fertility and recurrence.

Verified
Journal Article
Open access
PDF file
KCKarolina Chmaj-Wierzchowska
Karolina Chmaj-Wierzchowska
OPOlga Połukord
Olga Połukord
OBOliwia Bajer
Oliwia Bajer
MCMaja Czyżewska
Maja Czyżewska
NHNatalia Handke
Natalia Handke
MWMaciej Wilczak
Maciej Wilczak
Background: Uterine fibroids are the most common benign tumors of the female reproductive system and frequently affect women’s health-related quality of life (HRQoL). The increasing use of online surveys in clinical research raises concerns regarding the comparability and reliability of data collected through different recruitment methods. This study aimed to compare the clinical and methodological comparability of data obtained from an online survey and a clinic-based survey assessing symptom severity and HRQoL among women diagnosed with uterine fibroids. Methods: A cross-sectional observational study was conducted among 167 women with confirmed uterine fibroids. The clinic-based cohort included 82 patients recruited in a gynecological outpatient clinic, while the online cohort consisted of 85 women participating through an internet-based survey. Both cohorts were assessed using identical inclusion and exclusion criteria, the same questionnaire structure, and the validated Uterine Fibroid Symptom and Health-Related Quality of Life (UFS-QoL) instrument. Symptom severity scores and HRQoL outcomes were compared descriptively and methodologically. Results: The two independently recruited cohorts showed broadly similar distributions of several demographic characteristics and patient-reported outcomes, although important differences between the source populations should be considered when interpreting these findings. Mean symptom severity scores were 48.55 ± 21.61 in the clinic-based cohort and 46.33 ± 21.40 in the online cohort, while mean HRQoL scores were 57.23 ± 22.81 and 62.50 ± 19.32, respectively. Formal comparisons revealed no significant differences in symptom severity (p = 0.506) or overall HRQoL (p = 0.110). Among the six UFS-QoL domains, only the Concern domain differed significantly between cohorts (p = 0.005), whereas all other domains showed broadly similar distributions. Separate multivariable regression models were fitted for each cohort. Although direct comparison of the models was limited by differences in variable coding, both models identified symptom severity as the strongest independent predictor of HRQoL (β = −0.715 and β = −0.752) and showed similar overall model performance (R2 = 0.595 and 0.578). Regression diagnostics confirmed normality of residuals, homoscedasticity, absence of influential outliers, and low variance inflation factors in both datasets. Conclusions: Despite differences in recruitment setting and source population, similar patterns of patient-reported HRQoL and symptom severity were observed across the two independently recruited cohorts. Similarities were observed across overall HRQoL scores, symptom severity measures, and multivariable regression models, suggesting that the relationships between symptom burden and quality of life remained consistent across recruitment methods. Although differences were identified in disease-related concerns and reproductive history, these findings did not substantially alter the overall pattern of results. Taken together, the findings demonstrate that similar patterns of patient-reported HRQoL and symptom severity were observed across two independently recruited cohorts of women with uterine fibroids. These findings support the feasibility of collecting disease-specific patient-reported outcomes within uterine fibroid-specific online communities but should not be interpreted as evidence that online and clinic-based recruitment methods generate equivalent study populations.